Palisade Bio (PALI) Non Operating Income (2010 - 2026)
Palisade Bio (PALI) reported Non Operating Income of $1.1 million for Q1 2026, up 1317.28% year-over-year from $81000.0 in Q1 2025, and up 6.89% quarter-over-quarter from $1.1 million in Q4 2025.
Palisade Bio (PALI) Non Operating Income (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Non Operating Income data on file, last reported at $1.1 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at $1.1 million, up 1317.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (up 542.86% YoY), and the FY2025 annual result was $1.3 million, up 202.85% from the prior year.
- Non Operating Income rose to $1.1 million in Q1 2026 per PALI's latest filing, from $1.1 million in the prior quarter.
- Over five years, Non Operating Income peaked at $1.2 million in Q2 2022 and troughed at -$317000.0 in Q1 2022.
- A 5-year average of $298882.4 and a median of $146000.0 in 2024 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 7575.0% in 2022 and fell as far as 97.49% in 2022.
- A 5-year view of Non Operating Income shows it stood at $128000.0 in 2022, then soared by 42.97% to $183000.0 in 2023, then plunged by 79.23% to $38000.0 in 2024, then soared by 2726.32% to $1.1 million in 2025, then increased by 6.89% to $1.1 million in 2026.
- Business Quant data shows PALI's Non Operating Income at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $59000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 133,000.00 |
| Mar 31, 2024 | 146,000.00 |
| Dec 31, 2023 | 183,000.00 |
| Sep 30, 2023 | 182,000.00 |
| Jun 30, 2023 | 216,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 128,000.00 |
| Sep 30, 2022 | 422,000.00 |
| Jun 30, 2022 | 1.23 Mn |
| Mar 31, 2022 | -317,000.00 |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 11.10 Mn |
| Jun 30, 2021 | 16,000.00 |